(EMAILWIRE.COM, January 18, 2017 ) According to the report Europe Nuclear Medicine Radiopharmaceuticals, published by Market Data Forecast, the market is projected to reach USD 1,780 Million by 2020, at a CAGR of 11.4% from 2015 to 2020. Germany is likely to witness a significant growth in the forecast period fuelled with the recent developments in the field.

For full report refer to http://www.marketdataforecast.com/market-reports/europe-nuclear-medicine-radiopharmaceuticals-market-131/

Nuclear Medicine involves usage of radioactive material in minute amounts for the diagnosis and treatment of the disease. Radiopharmaceuticals Market emits gamma radiations targeting a specific site or organ. The different routes of administration of the radiopharmaceuticals inside the body includes inhalation, oral or injection depending on the type of drug and targeted organ.

Free sample of the report is available at http://www.marketdataforecast.com/market-reports/europe-nuclear-medicine-radiopharmaceuticals-market-131/request-sample

There has been a significant rise of the Radiopharmaceutical market in the recent years with the rising prevalence of cancer and cardiac ailments. The market is also fuelled by the innovations in the field of nuclear medicine and technological advancements, growing demand for the PET and SPECT applications coupled with the rising public awareness on healthcare. The recent development of the integration of X-ray tomography (CT) into SPECT which has also emerged as an excellent diagnostic tool in the medical imaging is also contributing to the growth of the market.

Enquire more about the report here http://www.marketdataforecast.com/market-reports/europe-nuclear-medicine-radiopharmaceuticals-market-131/inquire

The Nuclear Medicine Radiopharmaceuticals is segmented as following:
Diagnostic Radioisotopes
SPECT
• Technetium-99m
• Thallium-201
• Gallium-67
• Iodine-23
• Others
PET
• Fluorine-18
• Rubidium-82
• Others
Therapeutic Radio Isotopes
Beta Emitters
• Iodine-131
• Yttrium-90
• Samarium-153
• Rhenium-186
• Lutetium-177
Alpha Emitters
• Radium-223
Brachytherapy
• Cesium-131
• Iodine-125
• Palladium-103
• Iridium-192
By Application
• Cardiology
• Lymphoma
• Thyroid
• Neurology
• Oncology
• Others

Request for Discount @ http://www.marketdataforecast.com/market-reports/europe-nuclear-medicine-radiopharmaceuticals-market-131/request-discount

The major companies operating in Europe Nuclear Medicine Radiopharmaceuticals market are GE Healthcare, Medix Inc., Hologic Inc., Positron Corporation, Segami Corporation, Naviscan Inc., Bracco Imaging S.p.A, Lantheus Medical Imaging, Inc., Bayer Healthcare and IBA Molecular Imaging.

Buy Now @ http://www.marketdataforecast.com/cart/buy-now/europe-nuclear-medicine-radiopharmaceuticals-market-131

The Europe Nuclear Medicine Radiopharmaceuticals market study offers the following deliverables:
• Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
• Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
• Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
• Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
• Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
• A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
• Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

Checkout other related studies in the Pharmaceuticals Segment:

Europe Nuclear Imaging Market: http://www.marketdataforecast.com/market-reports/europe-nuclear-imaging-market-1625/

Europe Nuclear Medicine Diagnostics Market: http://www.marketdataforecast.com/market-reports/europe-nuclear-medicine-diagnostics-market-125/

Europe Precision Medicine Market: http://www.marketdataforecast.com/market-reports/europe-precision-medicine-market-1477/

Europe Regenerative Medicines Market: http://www.marketdataforecast.com/market-reports/europe-regenerative-medicines-market-274/

About Us:

Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.

Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results